ACT Venture Partners — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

Cellbrickscellbricks-therapeutics.com inMar 2026

Cellbricks Therapeutics is a preclinical biotech company developing implantable tissue grafts using proprietary bioprinting technology, biomaterials, and human cells for regenerative medicine applications.

AI & Machine LearningBiotechDeep TechLongevityBerlin, DE

Alexander Leutner(Co-CEO (Business) & Co-founder)inDr. Tobias Lam(CTO & Co-founder)Alexander Thomas(Soft Tissue Program Lead & Co-founder)inMichael Kring(Chief Financial Officer)

Co-investorsAurum Venture Partners Creative Destruction Lab (CDL)Riceberg Ventures Premier VU Venture Partners Silicon Roundabout Ventures

Qubitriumqubitrium.tech inApr 2026

Qubitrium is a company focused on quantum technology innovation.

Deep TechHardwareQuantum Computing

Kadir Durak(Founder)in

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.